Expression of Fos, Jun, and Krox family proteins in Alzheimer's disease

Experimental Neurology

Volumn 147, Issue 2, 1997, Pages 316-332

  MacGibbon, G A ^a   Lawlor, P A ^a   Walton, M ^a   Sirimanne, E ^a   Faull, R L M ^a   Synek, B ^a   Mee, E ^b   Connor, B ^a   Dragunow, M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL DEATH; CHROMATIN CONDENSATION; DNA BINDING; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN FAMILY; TRANSCRIPTION REGULATION;

EID: 0031259551     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6600     Document Type: Article

References (84)

1. Abraham W. C., Dragunow M., Tate W. P. The role of immediate early genes in the stabilization of long-term potentiation. Mol. Neurobiol. 5:1992;297-314.
2. Anderson A. J., Cummings B. J., Cotman C. W. Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease: Association with pathology. Exp. Neurol. 125:1994;286-295.
3. Anderson A. J., Pike C. J., Cotman C. W. Differential induction of immediate early gene proteins in cultured neurons by β-amyloid (Aβ): Association of c-Jun with Aβ-induced apoptosis. J. Neurochem. 65:1995;1487-1498.
4. Anderson A. J., Su J. H., Cotman C. W. DNA damage and apoptosis in Alzheimer's Disease: Colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J. Neurosci. 16:1996;1710-1719.
5. Behl C., Davis J. B., Klier F. G., Schubert D. Amyloid β peptide induces necrosis rather than apoptosis. Brain Res. 645:1994;253-264.
6. Benbrook D. M., Jones N. C. Heterodimer formation between CREB and JUN proteins. Oncogene. 5:1990;295-302.
7. Bliss T. V. P., Collingridge G. L. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
8. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
9. Cao X., Koski R. A., Gashler A., McKernan M., Morris C. F., Gaffney R., Hay R. V., Sukhatme V. P. Identification and characterization of the Egr-1 gene product, a DNA-binding zinc finger protein induced by differentiation and growth signals. Mol. Cell. Biol. 10:1990;1931-1939.
10. Chavrier P., Janssen-Timmen U., Mattéi M.-G., Zerial M., Bravo R., Charnay P. Structure, chromosome location, and expression of the mouse zinc finger geneKrox-20:fos. Mol. Cell. Biol. 9:1989;787-797.
11. 01. EMBO J. 7:1988;29-35.
12. Chiu R., Boyle W. J., Meek J., Smeal T., Hunter T., Karin M. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell. 54:1988;541-552.
13. Christy B. A., Lau L. F., Nathans D. A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with "zinc finger" sequences. Proc. Natl. Acad. Sci. USA. 85:1988;7857-7861.
14. Christy B., Nathans D. DNA binding site of the growth factor-inducible protein Zif268. Proc. Natl. Acad. Sci. USA. 86:1989;8737-8741.
15. Cohen D. R., Ferreira C. P., Gentz R., Franza Jr B. R., Curran T. The product of afosfra. Genes Dev. 3:1989;173-184.
16. Colotta F., Polentarutti N., Sironi M., Mantovani A. Expression and involvement of c-fosjun. J. Biol. Chem. 267:1992;18278-18283.
17. Cotman C. W., Anderson A. J. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10:1995;19-45.
18. Curran T., Franza B. R. Jr. Fos and Jun: The AP-1 connection. Cell. 55:1988;395-397.
19. Davis-Salinas J., Saporito-Irwin S. M., Cotman C. W., Van Nostrand W. E. Amyloid β-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J. Neurochem. 65:1995;931-934.
20. Day M. L., Zhao X., Wu S., Swanson P. E., Humphrey P. A. Phorbol ester-induced apoptosis is accompanied by NGFI-A and c-fos. Cell Growth Differ. 5:1994;735-741.
21. Douglas R. J. The hippocampus and behaviour. Psychol. Bull. 67:1967;416-442.
22. Dragunow M., Beilharz E., Sirimanne E., Lawlor P., Williams C., Bravo R., Gluckman P. Immediate-early gene protein expression in neurons undergoing delayed death, but not necrosis, following hypoxic-ischaemic injury to the young rat brain. Mol. Brain Res. 25:1994;19-33.
23. Dragunow M., Preston K. The role of inducible transcription factors in apoptotic nerve cell death. Brain Res. Rev. 21:1995;1-28.
24. Dragunow M., Yamada N., Bilkey D. K., Lawlor P. Induction of immediate-early gene proteins in dentate granule cells and somatostatin interneurons after hippocampal seizures. Mol. Brain Res. 13:1992;119-126.
25. Dragunow M., Young D., Hughes P., MacGibbon G., Lawlor P., Singleton K., Sirimanne E., Beilharz E., Gluckman P. Is c-Jun involved in nerve cell death following status epilepticus and hypoxic-ischaemic brain injury? Mol. Brain Res. 18:1993;347-352.
26. Estus S., Zaks W. J., Freeman R. S., Gruda M., Bravo R., Johnson E. M. Jr. Altered gene expression in neurons during programmed cell death: Identification of c-jun. J. Cell Biol. 127:1994;1717-1727.
27. Ferrer I., Seguí J., Olivé M. Strong c-Jun immunoreactivity is associated with apoptotic cell death in human tumors of the central nervous system. Neurosci. Lett. 214:1996;49-52.
28. Forloni G., Chiesa R., Smiroldo S., Verga L., Salmona M., Tagliavini F., Angeretti N. Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25-35. NeuroReport. 4:1993;523-526.
29. Gajate C., Alonso M. T., Schimmang T., Mollinedo F. c-Fos is not essential for apoptosis. Biochem. Biophys. Res. Commun. 218:1996;267-272.
30. Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
31. Gibson P. H., Tomlinson B. E. Numbers of Hirano bodies in the hippocampus of normal and demented people with Alzheimer's disease. J. Neurol. Sci. 33:1977;199-206.
32. Glenner G. G., Wong C. W. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:1984;885-890.
33. 1-42. J. Neurochem. 65:1995;292-300.
34. Gunn A. J., Dragunow M., Faull R. L. M., Gluckman P. D. Effects of hypoxia-ischemia and seizures on neuronal and glial-like c-fos. Brain Res. 531:1990;105-116.
35. Halazonetis T. D., Georgopoulos K., Greenberg M. E., Leder P. c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell. 55:1988;917-924.
36. Halliday G. M., Cullen K. M., Kril J. J., Harding A. J., Harasty J. Glial fibrillary acidic protein (GFAP) immunohistochemistry in human cortex: A quantitative study using different antisera. Neurosci. Lett. 209:1996;29-32.
37. Herdegen T., Kiessling M., Bele S., Bravo R., Zimmermann M., Gass P. The KROX-20 transcription factor in the rat central and peripheral nervous systems: Novel expression pattern of an immediate early gene-encoded protein. Neuroscience. 57:1993;41-52.
38. Hirano A., Dembitzer H. M., Kurland L. T., Zimmerman H. M. The fine structure of some intraganglionic alterations. Neurofibrillary tangles, granulovacuolar bodies, and "rod-like" structures as seen in Guam amyotrophic lateral sclerosis and parkinsonism-dementia complex. J. Neuropathol. Exp. Neurol. 27:1968;167-182.
39. Hooper M. W., Vogel F. S. The limbic system in Alzheimer's disease. Am. J. Pathol. 85:1976;1-13.
40. Hughes P., Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharm. Rev. 47:1995;133-178.
41. Kerr J. F. R., Wyllie A. H., Currie A. R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
42. Kesslak J. P., Nalcioglu O., Cotman C. W. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology. 41:1991;51-54.
43. 1. Mol. Brain Res. 13:1992;93-101.
44. 01. Mol. Cell. Biol. 11:1991;2451-2459.
45. Kovary K., Bravo R. The Jun and Fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell. Biol. 11:1991;4466-4472.
46. Lassmann H., Bancher C., Breitschopf H., Wegiel J., Bobinski M., Jellinger K., Wisniewski H. M. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol. 89:1995;35-41.
47. 1-40. J. Neurochem. 65:1995;2373-2376.
48. Lemaire P., Revelant O., Bravo R., Charnay P. Two mouse genes encoding potential transcription factors with identical DNA-binding domains are activated by growth factors in cultured cells. Proc. Natl. Acad. Sci. USA. 85:1988;4691-4695.
49. Liu Z.-G., Smith S. W., McLaughlin K. A., Schwartz L. A., Osborne B. A. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early genenur77. Nature. 367:1994;281-284.
50. Loo D. T., Copani A., Pike C. J., Whittemore E. R., Walencewicz A. J., Cotman C. W. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA. 90:1993;7951-7955.
51. MacGibbon G. A., Lawlor P. A., Bravo R., Dragunow M. Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Mol. Brain Res. 23:1994;21-32.
52. MacGibbon G. A., Lawlor P. A., Sirimanne E. S., Walton M. R., Connor B., Young D., Williams C., Gluckman P., Faull R. L. M., Hughes P., Dragunow M. Bax expression in mammalian neurons undergoing apoptosis and in Alzheimer's disease hippocampus. Brain Res. 750:1996;223-234.
53. Macgregor P. F., Abate C., Curran T. Direct cloning of leucine zipper proteins: Jun binds cooperatively to the CRE with CRE-BP1. Oncogene. 5:1990;451-458.
54. Maciver S. K., Harrington C. R. Two actin binding proteins, actin depolymerizing factor and cofilin, are associated with Hirano bodies. NeuroReport. 6:1995;1985-1988.
55. Masliah E., Terry R. D., DeTeresa R., Hansen L. A. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci. Lett. 103:1989;234-239.
56. Masters C. L., Multhaup G., Simms G., Pottgiesser J., Martins R. N., Beyreuther K. Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J. 4:1985;2757-2763.
57. Migheli A., Cavalla P., Piva R., Giordana M. T., Schiffer D. bcl-2 protein expression in aged brain and neurodegenerative diseases. NeuroReport. 5:1994;1906-1908.
58. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., van Belle G., Berg L. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
59. Morris R. G., Kopelman M. D. The memory deficits in Alzheimer-type dementia: A review. Q. J. Exp. Psychol. 38A:1986;575-602.
60. Myers R. H., Vonsattel J. P., Paskevich P. A., Kiely D. K., Stevens T. J., Cupples L. A., Richardson E. P., Bird E. D. Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. J. Neuropathol. Exp. Neurol. 50:1991;729-742.
61. Nakabeppu Y., Ryder K., Nathans D. DNA binding activities of three murine Jun proteins: Stimulation by Fos. Cell. 55:1988;907-915.
62. Quitschke W. W., Goldgaber D. The amyloid β-protein precursor promoter. J. Biol. Chem. 267:1992;17362-17368.
63. Richardson C. L., Tate W. P., Mason S. E., Lawlor P. A., Dragunow M., Abraham W. C. Correlation between the induction of an immediate early gene,zif/268, Brain Res. 580:1992;147-154.
64. Roberts G. W., Nash M., Ince P. G., Royston M. C., Gentleman S. M. On the origin of Alzheimer's disease: A hypothesis. NeuroReport. 4:1993;7-9.
65. Roffler-Tarlov S., Gibson Brown J. J., Tarlov E., Stolarov J., Chapman D. L., Alexiou M., Papaioannou V. E. Programmed cell death in the absence of c-Fos and c-Jun. Development. 122:1996;1-9.
66. Ryseck R.-P., Bravo R. c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins. Oncogene. 6:1991;533-542.
67. Salbaum J. M., Weidemann A., Lemaire H.-G., Masters C. L., Beyreuther K. The promoter of Alzheimer's disease amyloid A4 precursor gene. EMBO J. 7:1988;2807-2813.
68. Satou T., Cummings B. J., Cotman C. W. Immunoreactivity for Bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity. Brain Res. 697:1995;35-43.
69. Selkoe D. J. Normal and abnormal biology of the β-amyloid precursor protein. Annu. Rev. Neurosci. 17:1994;489-517.
70. Sheng M., Greenberg M. E. The regulation and function of c-fos. Neuron. 4:1990;477-485.
71. Sirimanne E. S., Guan J., Williams C. E., Gluckman P. D. Two models for determining the mechanisms of damage and repair after hypoxic-ischaemic injury in the developing rat brain. J. Neurosci. Methods. 55:1994;7-14.
72. Smeyne R. J., Vendrell M., Hayward M., Baker S. J., Miao G. G., Schilling K., Robertson L. M., Curran T., Morgan J. I. Continuous c-fosin vivo. Nature. 363:1993;166-169.
73. Squire L. R., Zola-Morgan S. Memory: Brain systems and behaviour. Trends Neurosci. 11:1988;170-175.
74. Su J. H., Deng G., Cotman C. W. Bax protein expression is increased in Alzheimer's brain: Correlations with DNA damage, Bcl-2 expression, and brain pathology. J. Neuropathol. Exp. Neurol. 56:1997;86-93.
75. Sukhatme V. P., Cao X., Chang L. C., Tsai-Morris C.-H., Stamenkovich D., Ferreira P. C. P., Cohen D. R., Edwards S. A., Shows T. B., Curran T., Le Beau M. M., Adamson E. D. A zinc finger-encoding gene coregulated with c-fos. Cell. 53:1988;37-43.
76. Terry R. D., Peck A., DeTeresa R., Schechter R., Horoupian D. S. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann. Neurol. 10:1981;184-192.
77. Trejo J., Massamiri T., Deng T., Dewji N. N., Bayney R. M., Brown J. H. A direct role for protein kinase C and the transcription factor Jun/AP-1 in the regulation of the Alzheimer's β-amyloid precursor protein gene. J. Biol. Chem. 269:1994;21682-21690.
78. Van Hoesen G. W., Hyman B. T. Hippocampal formation: Anatomy and the patterns of pathology in Alzheimer's disease. Prog. Brain Res. 83:1990;445-457.
79. Vonsattel J.-P., Myers R. H., Stevens T. J., Ferrante R. J., Bird E. D., Richardson E. P. Jr. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44:1985;559-577.
80. Williams J., Dragunow M., Lawlor P., Mason S., Abraham W. C., Leah J., Bravo R., Demmer J., Tate W. Krox20 may play a key role in the stabilization of long-term potentiation. Mol. Brain Res. 28:1995;87-93.
81. Wyllie A. H. Cell death: A new classification separating apoptosis from necrosis. Cell Death in Biology and Pathology. 1981;Chapman & Hall, New York. p. 9-34.
82. 1. Proc. Natl. Acad. Sci. USA. 88:1991;1291-1295.
83. Zerial M., Toschi L., Ryseck R.-P., Schuermann M., Müller R., Bravo R. The product of a novel growth factor activated gene,fos B, EMBO J. 8:1989;805-813.
84. Zhang P., Hirsch E. C., Damier P., Duyckaerts C., Javoy-Agid F. c-fos protein-like immunoreactivity: Distribution in the human brain and over-expression in the hippocampus of patients with Alzheimer's disease. Neuroscience. 46:1992;9-21.